§ Federal grant opportunity · HT942526TERPCTA
DoW Toxic Exposures Clinical Trial Award
Ebony S Simmons Grantor is accepting applications for DoW Toxic Exposures Clinical Trial Award. The deadline is November 19, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- Ebony S Simmons Grantor
- Application deadline
- November 19, 2026
- Award range
- Award amount not published
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Research
- Opportunity number
- HT942526TERPCTA
Program overview
Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment, or management of symptoms, diseases or conditions associated with or resulting from military-related toxic exposures. Proposed projects may range from small proof-of-concept clinical trials (e.g., pilot, first-in-human, phase 0) designed to demonstrate the feasibility or inform the design of more advanced trials, through large-scale trials (including pragmatic clinical trials) to determine efficacy in relevant patient populations. Distinctive Features: To encourage applications that include meaningful and productive collaborations, the FY26 TERP CTA includes a Partnering Principal Investigator Option (PPIO) . One Principal Investigator (PI) is identified as the initiating PI, and an additional PI may be identified as a Partnering PI. If recommended for funding, each PI will be named on separate awards. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists, that will accelerate the movement of promising interventions/knowledge products into clinical applications. Partnering should significantly advance the research beyond what would be possible through independent efforts. https://cdmrp.health.mil/pubs/press/2026/terppreann
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Ebony S Simmons Grantor.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before November 19, 2026, allowing time for registration and validation.
Related grant opportunities
- DoW Toxic Exposures Investigator Initiated Research Award
- DoW Toxic Exposures Translational Research Award
- Louis Stokes Alliances for Minority Participation
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.